AcelRx Announces Positive CHMP Opinion for Zalviso in the Management of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients
MB Financial, Inc. Reports Record Earnings for the Second Quarter 2015, Combined with Solid Loan Growth
Zalviso™ Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
PCA's customer mix strategy is proving to be effective.
With fewer M&A opportunities, we think industry buyback activity will increase through 2017.
The market seems smitten with the newfound pricing power in the industry, but it won't last.